Gozo MC - Search Results

1

Foxc2 induces Wnt4 and Bmp4 expression during muscle regeneration and osteogenesis.

Gozo MC, Aspuria PJ, Cheon DJ, Walts AE, Berel D, Miura N, Karlan BY, Orsulic S. Gozo MC, et al. Cell Death Differ. 2013 Aug;20(8):1031-42. doi: 10.1038/cdd.2013.34. Epub 2013 May 3. Cell Death Differ. 2013. PMID: 23645207 Free PMC article.

2

FOXC2 augments tumor propagation and metastasis in osteosarcoma.

Gozo MC, Jia D, Aspuria PJ, Cheon DJ, Miura N, Walts AE, Karlan BY, Orsulic S. Gozo MC, et al. Oncotarget. 2016 Oct 18;7(42):68792-68802. doi: 10.18632/oncotarget.11990. Oncotarget. 2016. PMID: 27634875 Free PMC article.

3

HOXB13 controls cell state through super-enhancers.

Aspuria PJ, Cheon DJ, Gozo MC, Beach JA, Recouvreux MS, Walts AE, Karlan BY, Orsulic S. Aspuria PJ, et al. Among authors: gozo mc. Exp Cell Res. 2020 Aug 1;393(1):112039. doi: 10.1016/j.yexcr.2020.112039. Epub 2020 May 4. Exp Cell Res. 2020. PMID: 32376288 Free article.

4

FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer.

Recouvreux MS, Miao J, Gozo MC, Wu J, Walts AE, Karlan BY, Orsulic S. Recouvreux MS, et al. Among authors: gozo mc. Cancers (Basel). 2022 Oct 4;14(19):4851. doi: 10.3390/cancers14194851. Cancers (Basel). 2022. PMID: 36230774 Free PMC article.

5

Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism.

Aspuria PP, Lunt SY, Väremo L, Vergnes L, Gozo M, Beach JA, Salumbides B, Reue K, Wiedemeyer WR, Nielsen J, Karlan BY, Orsulic S. Aspuria PP, et al. Cancer Metab. 2014 Dec 15;2:21. doi: 10.1186/2049-3002-2-21. eCollection 2014. Cancer Metab. 2014. PMID: 25671108 Free PMC article.

6

Integrin αvβ3 drives slug activation and stemness in the pregnant and neoplastic mammary gland.

Desgrosellier JS, Lesperance J, Seguin L, Gozo M, Kato S, Franovic A, Yebra M, Shattil SJ, Cheresh DA. Desgrosellier JS, et al. Dev Cell. 2014 Aug 11;30(3):295-308. doi: 10.1016/j.devcel.2014.06.005. Dev Cell. 2014. PMID: 25117682 Free PMC article.

7

Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.

Wernig G, Kharas MG, Okabe R, Moore SA, Leeman DS, Cullen DE, Gozo M, McDowell EP, Levine RL, Doukas J, Mak CC, Noronha G, Martin M, Ko YD, Lee BH, Soll RM, Tefferi A, Hood JD, Gilliland DG. Wernig G, et al. Cancer Cell. 2008 Apr;13(4):311-20. doi: 10.1016/j.ccr.2008.02.009. Cancer Cell. 2008. PMID: 18394554 Free article.

8

Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice.

Kharas MG, Okabe R, Ganis JJ, Gozo M, Khandan T, Paktinat M, Gilliland DG, Gritsman K. Kharas MG, et al. Blood. 2010 Feb 18;115(7):1406-15. doi: 10.1182/blood-2009-06-229443. Epub 2009 Dec 14. Blood. 2010. PMID: 20008787 Free PMC article.

9

Targeting the Achilles' heel of drug-resistant cancer stem cells.

Seguin L, Gozo M, Weis SM, Cheresh DA. Seguin L, et al. Cell Cycle. 2014;13(13):2017-8. doi: 10.4161/cc.29460. Epub 2014 Jun 6. Cell Cycle. 2014. PMID: 24906000 Free PMC article. No abstract available.

10

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.

Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M, Cuker A, Wernig G, Moore S, Galinsky I, DeAngelo DJ, Clark JJ, Lee SJ, Golub TR, Wadleigh M, Gilliland DG, Levine RL. Pikman Y, et al. PLoS Med. 2006 Jul;3(7):e270. doi: 10.1371/journal.pmed.0030270. PLoS Med. 2006. PMID: 16834459 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters